Effects of tempol on altered metabolism and renal vascular responsiveness in fructose-fed rats

Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme
Mohammed H AbdullaE J Johns

Abstract

This study investigated the effect of tempol (a superoxide dismutase mimetic) on renal vasoconstrictor responses to angiotensin II (Ang II) and adrenergic agonists in fructose-fed Sprague-Dawley rats (a model of metabolic syndrome). Rats were fed 20% fructose in drinking water (F) for 8 weeks. One fructose-fed group received tempol (FT) at 1 mmol·L(-1) in drinking water for 8 weeks or as an infusion (1.5 mg·kg(-1)·min(-1)) intrarenally. At the end of the treatment regimen, the renal responses to noradrenaline, phenylephrine, methoxamine, and Ang II were determined. F rats exhibited hyperinsulinemia, hyperuricemia, hypertriglyceridemia, and hypertension. Tempol reduced blood glucose and insulin levels (all p < 0.05) in FT rats compared with their untreated counterparts. The vasoconstriction response to all agonists was lower in F rats than in control rats by about 35%-65% (all p < 0.05). Vasoconstrictor responses to noradrenaline, phenylephrine, and methoxamine but not Ang II were about 41%-75% higher in FT rats compared with F rats (all p < 0.05). Acute tempol infusion blunted responses to noradrenaline, methoxamine, and Ang II in control rats by 32%, 33%, and 62%, while it blunted responses to noradrenaline and Ang II in F rat...Continue Reading

References

Jan 1, 1991·Free Radical Research Communications·J V Hunt, S P Wolff
Mar 20, 1990·Biochemistry·J B MitchellA Russo
Mar 1, 1990·Clinical Rheumatology·E Collantes EstevezP Sanchez Guijo
Jan 1, 1995·The American Journal of Physiology·C M Hackney, D N Furness
Aug 1, 1996·American Journal of Hypertension·E MuscelliE Ferrannini
Jan 1, 1997·Circulation Research·H R MiddlekauffG G Gibbs
Jul 22, 1999·European Journal of Pharmacology·S VermaJ H McNeill
Jan 17, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Christine G Schnackenberg
Mar 1, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Tina ChabrashviliChristopher S Wilcox
Jun 7, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ya-Fei ChenAi-Ping Zou
Mar 6, 2004·American Journal of Hypertension·Yi ZhangJudith A Whitworth
Mar 31, 2004·Canadian Journal of Physiology and Pharmacology·R Tatchum-Talom, D S Martin
Apr 20, 2004·Current Opinion in Nephrology and Hypertension·Nosratola D Vaziri
May 11, 2004·Clinical and Experimental Hypertension : CHE·Yuri OzawaTakao Saruta
Jan 11, 2005·Cardiovascular Research·Beatriz SomozaMaría S Fernández-Alfonso
Aug 18, 2005·American Journal of Physiology. Renal Physiology·Libor KopkanDewan S A Majid
Jan 18, 2006·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Bhoomi ViswanadPoduri Ramarao
Mar 4, 2006·Journal of Applied Physiology·F M FaraciS P Didion
Jun 30, 2006·The Journal of Pharmacy and Pharmacology·Wen-Guang LiRong-Liang Zheng
Jul 18, 2006·Autonomic Neuroscience : Basic & Clinical·Vera FarahMariana Morris
Sep 5, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Armin JustWilliam J Arendshorst
Sep 28, 2006·Clinical and Experimental Pharmacology & Physiology·Marcos A MayerAna M Puyó
Apr 19, 2007·American Journal of Physiology. Endocrinology and Metabolism·Adam Whaley-ConnellJames R Sowers
Jan 25, 2008·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Juan Manuel MorenoFélix Vargas
Aug 15, 2008·American Journal of Physiology. Renal Physiology·Laura G Sánchez-LozadaRichard J Johnson
Dec 30, 2008·Pharmacological Reviews·Christopher S Wilcox, Adam Pearlman
May 15, 2009·Molecular and Cellular Biochemistry·Linda T TranJohn H McNeill
Aug 12, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Tim J M RobertsMarilyn J Cipolla

❮ Previous
Next ❯

Citations

Nov 28, 2018·Toxicology Mechanisms and Methods·Onur Gökhan YildirimFatma Akar
Aug 18, 2020·Life Sciences·Deborah de Farias LelisMarcelo Perim Baldo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.